Phase I and pharmacokinetic study of elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Giles, FJ; Vey, N; Rizzieri, D; Ravandi, F; Prebet, T; Borthakur, G; Jacobsen, TF; Hagen, S; Nilsson, B; O'Brien, S

Published Date

  • July 2012

Published In

Volume / Issue

  • 26 / 7

Start / End Page

  • 1686 - 1689

PubMed ID

  • 22222600

Pubmed Central ID

  • 22222600

Electronic International Standard Serial Number (EISSN)

  • 1476-5551

Digital Object Identifier (DOI)

  • 10.1038/leu.2012.1

Language

  • eng

Conference Location

  • England